Landmark study finds adding antidepressants to mood stabilizers may not yield greater benefits
Adjunctive atomoxetine fails to improve symptoms in patients with persistent depression
Sodium valproate and levetiracetam
Naltrexone and CBT for alcohol and eating disorders in women
Atomoxetine augmentation for depression: Accentuate the negative
Placebo-controlled trial of escitalopram for kleptomania
Study sheds light on genetic risk for schizophrenia
Psychosis possibly relating to zonisamide
From the FDA